197 related articles for article (PubMed ID: 31366824)
1. Identification of hepatokines involved in pathology of type 2 diabetes and obesity.
Misu H
Endocr J; 2019 Aug; 66(8):659-662. PubMed ID: 31366824
[TBL] [Abstract][Full Text] [Related]
2. Pathophysiological significance of hepatokine overproduction in type 2 diabetes.
Misu H
Diabetol Int; 2018 Oct; 9(4):224-233. PubMed ID: 30603372
[TBL] [Abstract][Full Text] [Related]
3. Circulating Concentrations of Insulin Resistance-Associated Hepatokines, Selenoprotein P and Leukocyte Cell-Derived Chemotaxin 2, during an Oral Glucose Tolerance Test in Humans.
Mohri K; Misu H; Takayama H; Ishii KA; Kikuchi A; Lan F; Enyama Y; Takeshita Y; Saito Y; Kaneko S; Takamura T
Biol Pharm Bull; 2019 Mar; 42(3):373-378. PubMed ID: 30606895
[TBL] [Abstract][Full Text] [Related]
4. LECT2 functions as a hepatokine that links obesity to skeletal muscle insulin resistance.
Lan F; Misu H; Chikamoto K; Takayama H; Kikuchi A; Mohri K; Takata N; Hayashi H; Matsuzawa-Nagata N; Takeshita Y; Noda H; Matsumoto Y; Ota T; Nagano T; Nakagen M; Miyamoto K; Takatsuki K; Seo T; Iwayama K; Tokuyama K; Matsugo S; Tang H; Saito Y; Yamagoe S; Kaneko S; Takamura T
Diabetes; 2014 May; 63(5):1649-64. PubMed ID: 24478397
[TBL] [Abstract][Full Text] [Related]
5. Hepatokine Selenoprotein P-Mediated Reductive Stress Causes Resistance to Intracellular Signal Transduction.
Takamura T
Antioxid Redox Signal; 2020 Sep; 33(7):517-524. PubMed ID: 32295394
[No Abstract] [Full Text] [Related]
6. Hepatokines and non-alcoholic fatty liver disease.
Lebensztejn DM; Flisiak-Jackiewicz M; Białokoz-Kalinowska I; Bobrus-Chociej A; Kowalska I
Acta Biochim Pol; 2016; 63(3):459-67. PubMed ID: 27262842
[TBL] [Abstract][Full Text] [Related]
7. A liver-derived secretory protein, selenoprotein P, causes insulin resistance.
Misu H; Takamura T; Takayama H; Hayashi H; Matsuzawa-Nagata N; Kurita S; Ishikura K; Ando H; Takeshita Y; Ota T; Sakurai M; Yamashita T; Mizukoshi E; Yamashita T; Honda M; Miyamoto K; Kubota T; Kubota N; Kadowaki T; Kim HJ; Lee IK; Minokoshi Y; Saito Y; Takahashi K; Yamada Y; Takakura N; Kaneko S
Cell Metab; 2010 Nov; 12(5):483-95. PubMed ID: 21035759
[TBL] [Abstract][Full Text] [Related]
8. [Novel strategies that target hepatokines for treatment of type 2 diabetes].
Misu H; Takamura T; Kaneko S
Nihon Rinsho; 2012 Jan; 70(1):157-63. PubMed ID: 22413512
[TBL] [Abstract][Full Text] [Related]
9. Selenoprotein P as a diabetes-associated hepatokine that impairs angiogenesis by inducing VEGF resistance in vascular endothelial cells.
Ishikura K; Misu H; Kumazaki M; Takayama H; Matsuzawa-Nagata N; Tajima N; Chikamoto K; Lan F; Ando H; Ota T; Sakurai M; Takeshita Y; Kato K; Fujimura A; Miyamoto K; Saito Y; Kameo S; Okamoto Y; Takuwa Y; Takahashi K; Kidoya H; Takakura N; Kaneko S; Takamura T
Diabetologia; 2014 Sep; 57(9):1968-76. PubMed ID: 24989996
[TBL] [Abstract][Full Text] [Related]
10. Protectin DX ameliorates palmitate-induced hepatic insulin resistance through AMPK/SIRT1-mediated modulation of fetuin-A and SeP expression.
Jung TW; Ahn SH; Shin JW; Kim HC; Park ES; Abd El-Aty AM; Hacımüftüoğlu A; Song KH; Jeong JH
Clin Exp Pharmacol Physiol; 2019 Oct; 46(10):898-909. PubMed ID: 31246318
[TBL] [Abstract][Full Text] [Related]
11. Deficiency of the hepatokine selenoprotein P increases responsiveness to exercise in mice through upregulation of reactive oxygen species and AMP-activated protein kinase in muscle.
Misu H; Takayama H; Saito Y; Mita Y; Kikuchi A; Ishii KA; Chikamoto K; Kanamori T; Tajima N; Lan F; Takeshita Y; Honda M; Tanaka M; Kato S; Matsuyama N; Yoshioka Y; Iwayama K; Tokuyama K; Akazawa N; Maeda S; Takekoshi K; Matsugo S; Noguchi N; Kaneko S; Takamura T
Nat Med; 2017 Apr; 23(4):508-516. PubMed ID: 28263310
[TBL] [Abstract][Full Text] [Related]
12. The influence of adiposity and acute exercise on circulating hepatokines in normal-weight and overweight/obese men.
Sargeant JA; Aithal GP; Takamura T; Misu H; Takayama H; Douglas JA; Turner MC; Stensel DJ; Nimmo MA; Webb DR; Yates T; King JA
Appl Physiol Nutr Metab; 2018 May; 43(5):482-490. PubMed ID: 29220580
[TBL] [Abstract][Full Text] [Related]
13. Metabolic Adaptation in Obesity and Type II Diabetes: Myokines, Adipokines and Hepatokines.
Oh KJ; Lee DS; Kim WK; Han BS; Lee SC; Bae KH
Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28025491
[TBL] [Abstract][Full Text] [Related]
14. Role of exercise-induced hepatokines in metabolic disorders.
Ennequin G; Sirvent P; Whitham M
Am J Physiol Endocrinol Metab; 2019 Jul; 317(1):E11-E24. PubMed ID: 30964704
[TBL] [Abstract][Full Text] [Related]
15. Do diabetes and obesity affect the metabolic response to exercise?
Plomgaard P; Weigert C
Curr Opin Clin Nutr Metab Care; 2017 Jul; 20(4):294-299. PubMed ID: 28375877
[TBL] [Abstract][Full Text] [Related]
16. [Clinical Importance of Non-alcoholic Fatty Liver Diseases. Topics: III. Relation with Type II diabetes: regulation by hepatokines].
Misu H
Nihon Naika Gakkai Zasshi; 2016 Jan; 105(1):25-30. PubMed ID: 27266040
[No Abstract] [Full Text] [Related]
17. Serum selenoprotein P levels in patients with type 2 diabetes and prediabetes: implications for insulin resistance, inflammation, and atherosclerosis.
Yang SJ; Hwang SY; Choi HY; Yoo HJ; Seo JA; Kim SG; Kim NH; Baik SH; Choi DS; Choi KM
J Clin Endocrinol Metab; 2011 Aug; 96(8):E1325-9. PubMed ID: 21677040
[TBL] [Abstract][Full Text] [Related]
18. Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance.
Meex RCR; Watt MJ
Nat Rev Endocrinol; 2017 Sep; 13(9):509-520. PubMed ID: 28621339
[TBL] [Abstract][Full Text] [Related]
19. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
Højlund K
Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
[TBL] [Abstract][Full Text] [Related]
20. Green tea extracts reduce leukocyte cell-Derived chemotaxin 2 and selenoprotein P levels in the livers of C57BL/6J mice fed a high-fat diet.
Onishi S; Kitazawa H; Meguro S; Tokimitsu I
Biosci Biotechnol Biochem; 2018 Sep; 82(9):1568-1575. PubMed ID: 29848194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
